ABBV
Drug Manufacturers - General · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when AbbVie Inc. publishes a filing, an earnings call transcript or a press release.
Get ABBV alertsRobert Michael is recorded as CFO at AbbVie Inc. (ABBV). The proxy statement of AbbVie Inc. reports total compensation of $8,772,853 for Robert Michael in fiscal 2019, including a base salary of $906,865. Disclosed compensation is on record for 2 fiscal years. Robert Michael has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for AbbVie Inc. on June 22, 2026. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Robert A. Michael (CEO, Chairman, CFO, COO and Board Member), Richard A. Gonzalez (Chairman), Scott T. Reents (CFO) and 5 others.
“Good morning, everyone, and thank you for joining us to discuss the acquisition of Apogee Therapeutics. Apogee will bolster AbbVie's leading immunology portfolio by adding multiple differentiated assets across several large and growing disease areas.”
“AbbVie's business continues to perform above our expectations. We delivered another excellent quarter, including strong financial results, pipeline advancement across all stages of development and strategic investments to drive sustainable long-term growth.”
“I mean it's tracking in line with our expectations. We're not saying that volume is worse than we originally guided. We're saying this is tracking in line with our expectations.”
“We're off to an excellent start in 2023, with each of our five key therapeutic areas meeting or exceeding our first quarter expectations, a testament to the strength of our broad portfolio.”
ABBV
Drug Manufacturers - General · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | AbbVie Inc. (ABBV) | CFO | $906,865 | $8,772,853 |
| 2018 | AbbVie Inc. (ABBV) | CFO | $553,654 | $3,118,888 |